Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Clayton

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
International Journal of Clinical Practice. Supplement|July 2, 2002
Is final height the only target of paediatric human growth hormone treatment?Peter E Clayton
Endocrinology and Metabolism Clinics of North America|March 6, 2007
Growth hormone treatment and cancer riskIndraneel Banerjee, Peter E Clayton
Endocrine Development|September 6, 2017
Ghrelin and GrowthReena Perchard, Peter E Clayton
BMJ (Clinical Research Ed.)|October 16, 2002
Adrenal insufficiency after treatment with fluticasone. Lowest possible dose of inhaled glucocorticoids should be givenLeena Patel, Peter E Clayton
Indian Journal of Pediatrics|November 23, 2011
Predicting response to growth hormone treatmentLeena Patel, Peter E Clayton
Pediatric Endocrinology Reviews : PER|July 4, 2006
Clinical utility of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 measurements in paediatric practiceIndraneel Banerjee, Peter E Clayton
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 25, 2013
Endocrine control of growthPhilip G Murray, Peter E Clayton
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 4, 2003
Growth hormone signal transduction and possible defects in childrenPeter E Clayton, Corinne M Silva
Hormone Research|November 16, 2005
Difficulties in patient management associated with the transition periodPeter E Clayton, Stephen M Shalet
Clinical Endocrinology|November 21, 2008
A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatmentAndrew J Whatmore, Leena Patel, Peter E Clayton
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Clinical Practice. Supplement|July 2, 2002
Is final height the only target of paediatric human growth hormone treatment?Peter E Clayton
Endocrinology and Metabolism Clinics of North America|March 6, 2007
Growth hormone treatment and cancer riskIndraneel Banerjee, Peter E Clayton
Endocrine Development|September 6, 2017
Ghrelin and GrowthReena Perchard, Peter E Clayton
BMJ (Clinical Research Ed.)|October 16, 2002
Adrenal insufficiency after treatment with fluticasone. Lowest possible dose of inhaled glucocorticoids should be givenLeena Patel, Peter E Clayton
Indian Journal of Pediatrics|November 23, 2011
Predicting response to growth hormone treatmentLeena Patel, Peter E Clayton
Pediatric Endocrinology Reviews : PER|July 4, 2006
Clinical utility of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 measurements in paediatric practiceIndraneel Banerjee, Peter E Clayton
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|April 25, 2013
Endocrine control of growthPhilip G Murray, Peter E Clayton
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 4, 2003
Growth hormone signal transduction and possible defects in childrenPeter E Clayton, Corinne M Silva
Hormone Research|November 16, 2005
Difficulties in patient management associated with the transition periodPeter E Clayton, Stephen M Shalet
Clinical Endocrinology|November 21, 2008
A pilot study to evaluate gene expression profiles in peripheral blood mononuclear cells (PBMCs) from children with GH deficiency and Turner syndrome in response to GH treatmentAndrew J Whatmore, Leena Patel, Peter E Clayton
Pageof 9